Akeso presented Phase Ib/II study results at ELCC 2026 showing cadonilimab combination therapy achieved 7.0 months median PFS and 95.2% DCR in immunotherapy-resistant advanced NSCLC patients with manageable safety profile.
Chinese collaborative robot company HUAYAN listed on Hong Kong Stock Exchange with market cap reaching HK$9 billion. The profitable cobot maker achieved 68.4% CAGR from 2022-2024, selling robots and core components globally.
Global fintech firm GTN appoints Dr. Franklin Yang as Greater China CEO, leveraging his 25 years of capital markets experience to drive regional growth following SFC Type 1 license approval.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.